Bank Pictet & Cie Europe AG Cuts Stake in UnitedHealth Group Incorporated $UNH

Key Points

• Bank Pictet & Cie Europe AG reduced its stake in UnitedHealth Group by 11.7%, resulting in ownership of 242,360 shares, which accounts for 1.6% of its investment portfolio.
• UnitedHealth Group reported $4.08 earnings per share for the latest quarter, missing expectations and showing a 12.9% increase in revenue year-over-year.
• Despite recent dips, 16 analysts have rated UnitedHealth Group with a consensus of "Moderate Buy" and a target price of $358.95.

Bank Pictet & Cie Europe AG lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 242,360 shares of the healthcare conglomerate's stock after selling 32,214 shares during the period. UnitedHealth Group comprises 1.6% of Bank Pictet & Cie Europe AG's investment portfolio, making the stock its 14th biggest position. Bank Pictet & Cie Europe AG's holdings in UnitedHealth Group were worth $75,609,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Bayforest Capital Ltd grew its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group during the 1st quarter valued at about $42,000. Copia Wealth Management purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $42,000. Finally, O Brien Wealth Partners LLC grew its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after acquiring an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $345.84 on Friday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The firm's 50 day moving average price is $299.96 and its 200-day moving average price is $361.40. The firm has a market cap of $313.22 billion, a P/E ratio of 14.98, a P/E/G ratio of 2.29 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Baird R W lowered shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Truist Financial boosted their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a report on Tuesday, September 9th. Sanford C. Bernstein boosted their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a report on Friday, September 5th. Finally, Bank of America boosted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.